abstract |
The present invention provides compounds for selectively inhibiting glycosidases with increased permeability, prodrugs of the compounds, and pharmaceutical compositions comprising the compounds or prodrugs of the compounds. The present invention also provides methods of treating diseases and disorders associated with deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc. |